financetom
Business
financetom
/
Business
/
Femasys Gets Australia, New Zealand Approvals for Two Products
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Femasys Gets Australia, New Zealand Approvals for Two Products
Jul 1, 2025 8:25 AM

11:00 AM EDT, 07/01/2025 (MT Newswires) -- Femasys ( FEMY ) said Tuesday it received regulatory approvals in Australia and New Zealand for FemaSeed as a first-line intratubal insemination treatment and FemVue as a diagnostic evaluation.

The shares were more than 2% lower in recent trading.

Price: 0.94, Change: -0.03, Percent Change: -2.69

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Vista Outdoor Gets Additional Information From MNC Capital on Revised Takeover Offer
Vista Outdoor Gets Additional Information From MNC Capital on Revised Takeover Offer
Jul 3, 2024
06:07 AM EDT, 07/03/2024 (MT Newswires) -- Vista Outdoor ( VSTO ) confirmed late Tuesday that it has received additional information from MNC Capital on a revised takeover offer of $42 per share. The additional information was obtained in response to Vista's request for certain information required to evaluate the proposal, the company said. Vista said it is reviewing the...
Identiv Receives Stockholder Approval for Asset Sale Transaction With Vitaprotech
Identiv Receives Stockholder Approval for Asset Sale Transaction With Vitaprotech
Jul 3, 2024
06:09 AM EDT, 07/03/2024 (MT Newswires) -- Identiv ( INVE ) said late Tuesday its stockholders approved the asset sale transaction with security solutions provider Vitaprotech for $145 million in cash. About 96% of the shares voted were in favor of the asset sale proposal as recommended by the company's board, representing about 72% of the company's outstanding shares. The...
Commerzbank on Overnight News
Commerzbank on Overnight News
Jul 3, 2024
06:06 AM EDT, 07/03/2024 (MT Newswires) -- Commerzbank in its European Sunrise note of Wednesday highlighted: Markets: Bull steepening subsides into New York close, front-end better offered in Asia. United States equity futures little changed after SPX closed on new highs, the US dollar (USD) stabilizes, yen (JPY) weakens to a 38-year low, oil also bid again. Fed: Federal Reserve...
Update: Market Chatter: Delaware Judge Rejects Drugmakers' Appeal to End Zantac Lawsuits
Update: Market Chatter: Delaware Judge Rejects Drugmakers' Appeal to End Zantac Lawsuits
Jul 3, 2024
06:03 AM EDT, 07/03/2024 (MT Newswires) -- (Updates with statement from GSK in fourth and fifth paragraphs.) A Delaware Superior Court judge rejected an appeal from GSK (GSK) and other drugmakers to overturn a ruling that cleared the way for over 70,000 lawsuits alleging that the heartburn drug Zantac causes cancer, Reuters reported late Monday. Judge Vivian Medinilla resoundingly rejected...
Copyright 2023-2025 - www.financetom.com All Rights Reserved